Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can’t keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company’s shares sky-high.

NASDAQ:BTRS - BTRS Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $20.00
  • Forecasted Upside: 69.92 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$11.77
▲ +0.31 (2.71%)

This chart shows the closing price for BTRS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New BTRS Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BTRS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BTRS

Analyst Price Target is $20.00
▲ +69.92% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for BTRS in the last 3 months. The average price target is $20.00, with a high forecast of $23.00 and a low forecast of $17.00. The average price target represents a 69.92% upside from the last price of $11.77.

This chart shows the closing price for BTRS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can’t keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company’s shares sky-high.

Current Consensus is Buy

The current consensus among 8 polled investment analysts is to buy stock in BTRS.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/11/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/11/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/9/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/7/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/5/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/6/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/5/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/4/2021

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/13/2021KeyCorpLower Price TargetOverweight$20.00 ➝ $18.00High
4/30/2021JPMorgan Chase & Co.Initiated CoverageNeutralHigh
4/22/2021CowenInitiated CoverageOutperform$17.00High
3/19/2021KeyCorpInitiated CoverageOverweight$20.00High
3/10/2021Needham & Company LLCInitiated CoverageBuy$20.00Medium
3/8/2021GuggenheimInitiated CoverageBuy$23.00High
3/1/2021CitigroupInitiated CoverageBuy$20.00Low
2/8/2021William BlairInitiated CoverageOutperformHigh
2/1/2021Canaccord GenuityInitiated CoverageBuy$22.00Low
(Data available from 8/5/2016 forward)
BTRS logo
BTRS Holdings Inc. provides cloud-based software and integrated payment processing solutions that simplify and automate B2B commerce. It offers solutions that span credit decisioning and monitoring, online ordering, invoicing, cash application, and collections. These solutions integrate with various ecosystem players, including financial institutions, enterprise resource planning systems, and accounts payable software platforms, to help customers to transition from paper invoicing and check acceptance to electronic billing and payments. The company's proprietary technology platform offers customers various ways to present invoices, such as online, email, AP portal, and print/mail; and receive payments through credit card, ACH, email, phone, and paper check. It serves customers across diversified industry verticals comprising technology, healthcare, industrial, wholesale distribution, consumer packaged goods, and others. The company was founded in 2001 and is headquartered in Lawrenceville, New Jersey.
Read More

Today's Range

Now: $11.77
Low: $11.27
High: $11.80

50 Day Range

MA: $13.48
Low: $11.46
High: $15.49

52 Week Range

Now: $11.77
Low: $10.02
High: $19.76

Volume

562,298 shs

Average Volume

614,372 shs

Market Capitalization

$1.85 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.31

Frequently Asked Questions

What sell-side analysts currently cover shares of BTRS?

The following Wall Street research analysts have issued reports on BTRS in the last twelve months: Canaccord Genuity, Citigroup Inc., Cowen Inc, Guggenheim, JPMorgan Chase & Co., KeyCorp, Needham & Company LLC, William Blair, and Zacks Investment Research.
View the latest analyst ratings for BTRS.

What is the current price target for BTRS?

6 Wall Street analysts have set twelve-month price targets for BTRS in the last year. Their average twelve-month price target is $20.00, suggesting a possible upside of 69.9%. Guggenheim has the highest price target set, predicting BTRS will reach $23.00 in the next twelve months. Cowen Inc has the lowest price target set, forecasting a price of $17.00 for BTRS in the next year.
View the latest price targets for BTRS.

What is the current consensus analyst rating for BTRS?

BTRS currently has 1 hold rating and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BTRS will outperform the market and that investors should add to their positions of BTRS.
View the latest ratings for BTRS.

What other companies compete with BTRS?

How do I contact BTRS's investor relations team?

BTRS's physical mailing address is 767 FIFTH AVENUE 9TH FLOOR, NEW YORK NY, 10153. The company's listed phone number is 609 235 1010 and its investor relations email address is [email protected] The official website for BTRS is www.billtrust.com.

Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can’t keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company’s shares sky-high.